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http://dx.doi.org/10.1016/j.jmii.2013Background/Purpose(s): To identify the clinical characteristics of cytomegalovirus (CMV) dis-
ease in chronic kidney disease (CKD) patients.
Methods: Patients from two sources were reviewed: (1) a retrospective study of hospitalized pa-
tients admitted between January 1990 and February 2009 was performed at a tertiary hospital in
Taiwan; (2) the English literature from1990 to 2009was reviewed for additional cases, and adults
with CKD and histopathologically documented cytomegalovirus disease were included.
Results: Seven CKD patients from our hospital and seven from the literature were included. Nine
(64.3%) patientsweremales, and themean agewas 66 years. Histopathologically proven CMVdis-
ease was present in the gastrointestinal (GI) tract of 13 (92.9%) and in the skin of one (7.1%)of Internal Medicine, National Cheng Kung University Hospital, Number 138, Sheng Li Road, Tainan
il.com (W.-C. Ko).
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346 Y.-M. Chen et al.patient. GI symptoms included bleeding (78.6%), abdominal pain (35.7%), and diarrhea
(28.6%).The most common comorbidities were diabetes mellitus (7, 50%) and hypertension
(8, 57.1%). Thirteen patients had CMV GI disease. The endoscopic gross features of the GI tract
lesions included single or multiple ulcers and a large polypoid or uneven surface mass. Of the
seven cases with available data, a low bodymass index (22.3 1.3 kg/m2) and hypoalbuminemia
(25  7.0 g/L) were noted. Twelve patients had received ganciclovir or valganciclovir therapy.
Five (35.7%) patients died, and the death of two patients was directly related to bowel perfora-
tion caused by CMV colitis.
Conclusion: CMV disease may occur in CKD patients without the presence of overt immunodefi-
ciency. The gastrointestinal tract is the most common site of involvement. Clinicians should be
aware of this possibility in CKD patients who have GI symptoms.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Cytomegalovirus (CMV) infections are common and world-
wide. The seroprevalence rate of cytomegalovirus infections
in adults was approximately 40e100% of the general popu-
lation.1 In immunocompromised individuals, such as those
with human immunodeficiency virus (HIV) infection or
transplant recipients, CMV can cause a broad spectrum of
diseases, including meningoencephalitis, pneumonitis,
hepatitis, retinitis and gastrointestinal (GI) ulcerations, and
is associated with significant morbidity and mortality.2,3
Although CMV infection is common in immunocompetent
adults, most infected adults show no symptoms or occa-
sionally show self-limited infectious mononucleosis, which
warrants no antiviral treatment.4
The prevalence of chronic kidney disease (CKD) in the
general population has been increasing in recent years.5,6
Data from the Department of Health in Taiwan indicates
that the prevalence of end-stage renal disease was 384/
million population in 1990 and increased to 1630/million
population in 2003.7 This prevalence and incidence of CKD in
Taiwan is relatively high compared with other countries.5,7
end-stage renal disease patients may have a higher risk of
encountering CMVbecause of frequent blood transfusion and
contaminated dialysis equipment when receiving hemodial-
ysis.8 Despite reports of high seroprevalenceofCMV infection
in CKD patients (66e84%), CMV disease in this population has
rarely been reported.9,10 The aim of the present study is to
determine the clinical presentation, laboratory findings, and
associated comorbidities of CMV disease in CKD patients.
Materials and methods
Study patients were obtained from two sources. First, a
retrospective study was performed at the National Cheng-
Kung University Hospital, a medical center in southern
Taiwan. Using the keyword “cytomegalovirus”, the discharge
database of patients admitted between January 1990 and
February 2009 was searched. The inclusion criteria were as
follows: adults (minimum age 18 years) with CKD, defined as
an estimated glomerular filtration rate of <60 mL/min/
1.73 m2 for at least 3 months, irrespective of the cause,8 and
clinical presentations that were compatible with active CMV
disease, as evidenced by either large viral inclusion bodies or
positive findings of CMV immunostaining on histologicalstudies of the biopsied tissues or resected sites. Immuno-
compromised patients, including those with HIV infections,
congenital or acquired immunodeficiency syndrome, his-
tories of allogeneic transplantation, malignancy, or the
receipt of immunosuppressive therapy, were excluded. The
medical records of patients with CKD and CMV disease were
reviewed for the demographic information, underlying dis-
eases, laboratory data, image findings, clinical courses, and
outcomes. The body mass index (BMI) is defined as the body
weight divided by the height2.
The second source of patients we reviewed was from a
literature search (1990e2009, computerized PubMed data-
base). The keywords used were “cytomegalovirus” and
“renal failure”, “renal insufficiency”, or “chronic kidney
disease”. The inclusion and exclusion criteria were the
same as those described in the case selection from our
hospital. The clinical information of the case reports and
detailed descriptions were extracted from the publications.
Results
Overall, 166 adults were clinically diagnosed as having CMV
infections at the study hospital between January 1990 and
February 2009. A total of 110 immunocompromised patients
were excluded, including 74 patients with organ trans-
plantation and immunosuppressive therapy, 30 with HIV
infection, and six with malignancy and chemotherapy
within the past month. Of the 56 immunocompetent pa-
tients with CMV infection, only 11 had histologically docu-
mented CMV disease. Seven of these 11 patients had CKD
and were included in the study. An additional seven pa-
tients with nonimmunocompromised CKD and active CMV
disease were identified in the English literature and eligible
for this analysis (Table 1).9e13
The clinical characteristics of the 14 patients with CKD
and active CMV infection are summarized in Tables 1 and 2.
Nine (64.3%) patients were males. The mean  standard
deviation age was 66.1  9.9 years, with 8 (57.1%) patients
older than 70 years. Nine (64.3%) patients had been
receiving regular hemodialysis. Other than CKD, the com-
mon comorbidities were hypertension (8, 57.1%) and dia-
betes mellitus (7, 50.0%). Complete blood cell counts were
available for 10 patients who presented with CMV disease.
Mild leukocytosis (mean 11.56  109 cells/L) and anemia
(mean hemoglobin concentration 92 g/L) were noted.
Table 1 Clinical characteristics of 14 chronic kidney disease patients with cytomegalovirus disease
Number Age (y) Sex Transfusion Involved site Chief
complaints
Gross presentation Albumin,
g/L
Antiviral
therapy
Outcome Reference
1 74 Male ND Esophagus Dysphagia Upper GI endoscopy: several yellow patches
with surrounding ulcer over the lower third of
the esophagus
30 Yes Survived
2 76 Male ND Duodenum GI bleeding Surgical finding: large, deep invading duodenal
ulcer, 20  20 mm in size, with perforation
20 Yes Died
3 54 Male ND Ileum GI bleeding Laparotomy: edematous ileum with congested,
dusty serosa and creeping mesenteric fat
ND Yes Survived 12
4 75 Female Yes Colon GI bleeding Colonoscopy: uneven surface tumor with bleeding 25 Yes Survived
5 75 Male Yes Colon GI bleeding Colonoscopy: multiple shallow ulcers 25 Yes Survived
6 66 Female No Colon GI bleeding Colonoscopy: broad base ulcers with edematous
surrounding folds
20 Yes Survived
7 77 Male No Colon GI bleeding Right hemicolectomy: uneven surface 21 Yes Died
8 74 Male Yes Colon GI bleeding Colonoscopy: diffuse and superficial ulcerations in
the colonic mucosa, with poor inflammatory
reactions
36 Yes Survived 11
9 74 Female ND Colon Abdominal pain,
GI bleeding
Colonoscopy: pancolitis ND Yes Died 13
10 71 Female ND Colon Diarrhea Colonoscopy: multiple colonic ulcers ND Yes Survived 13
11 59 Female Yes Colon GI bleeding Colonoscopy: severely inflamed mucosa with
multiple ulcerations
33.5 ND Survived 11
12 57 Male ND Colon GI bleeding Colonoscopy: a large polypoid mass ND Yes Survived 9
13 47 Male ND Anus Anal pain,
GI bleeding
Surgical finding: necrotic area over the anus 15 Yes Died
14 58 Male Yes Skin Skin rash Scaly erythematous macules and papules over
the buttocks and lower limbs
ND No Died 10
GI Z gastrointestinal; ND Z no data.
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Table 2 Summary of the clinical characteristics of 14
chronic kidney disease patients with cytomegalovirus
disease
Characteristics Mean  standard
deviation or n (%)
Male sex 9 (64.3)
Age, y 66.1  9.9
Hemodialysis 9 (64.3)
Comorbidity
Hypertension 8 (57.1)
Diabetes mellitus 7 (50.0)
Cerebrovascular accident 2 (14.3)
Liver cirrhosis 1 (7.1)
Chronic obstructive
pulmonary disease
1 (7.1)
Congestive heart failure 1 (7.1)
Clinical presentations
Fever 5 (35.7)
Gastrointestinal discomfort 14 (100.0)
Gastrointestinal bleeding 11 (78.6)
Abdominal pain 5 (35.7)
Diarrhea 4 (28.6)
Skin rash 1 (7.1)
Organ involvement
Gastrointestinal tract 13 (92.9)
Skin 1 (7.1)
Ganciclovir or valganciclovir
therapy
12 (85.7)
Mortality 5 (35.7)
348 Y.-M. Chen et al.The average bodyweight of the seven patients in the study
hospital was 60.4  9.5 kg, with a mean BMI of
22.3 1.3 kg/m2. Themean serum albumin was 25 7.0 g/L.
Cytomegalovirus antigenemia was assessed in five patients
and found in one (8 cells/2 105 leukocytes). Serum CMV IgM
was detected in one patient.
All but one patient had GI involvement that was caused
by CMV infection. The involved sites ranged from the upper
GI tract, including the esophagus and duodenum, to the
lower GI tract, including the ileum, colon and anus. The
gross features of the upper tract lesions were mainly single
or multiple ulcers that could be easily mistaken for
esophageal candidiasis (Fig. 1A). Colon involvement
included multiple ulcers and large polypoid or irregularFigure 1. Gross presentations of the gastrointestinal tract in th
logically proven cytomegalovirus disease. (A) Upper endoscopy show
the lower third of the esophagus (Case 1). Colonoscopy showed (B
broad base ulcers with edematous surrounding folds (Case 7).mass (Fig. 1B and C). All of the patients with CMV GI disease
had GI symptoms, including bleeding (11, 78.6%), abdom-
inal pain (5, 35.7%), and diarrhea (4, 28.6%).
The comorbidity of other organ systems with the GI tract
manifestations, including HenocheSchonlein purpura (in 1
case), was identified in a limited number of patients.12 The
affected patients seldom had fever. The only case of CMV
disease involving a body site other than the GI tract was a
patient with cutaneous CMV disease.10 However, the patient
died of upper GI bleeding.
Twelve patients had received intravenous ganciclovir or
oral valganciclovir therapy for an average of 23  14 days
(range, 7e42 days); one patient did not receive any anti-
viral therapy, and one had no available data. Of five (35.7%)
fatal cases, four patients had received antiviral therapy,
and one had experienced recurrent CMV colitis after 3
weeks of ganciclovir therapy. Two of the five fatalities died
of bowel perforations that were related to CMV colitis.Discussion
With the increased prevalence of CKD,6 clinicians should be
familiar with the clinical manifestations of CMV infection in
these patients. Although there is a high seroprevalence of
CMV infection in CKD patients, there have been only case
reports regarding CMV disease in these patients.9e13 In a
meta-analysis of CMV colitis in immunocompetent hosts,
the most common concomitant condition was renal fail-
ure.14 The pathogenesis underlying the association be-
tween CKD and CMV GI disease is unknown.
The sites of CMV disease in the digestive systems of CKD
patients ranged from the esophagus to the anus. A clinical
clue of CMV GI disease is GI bleeding, but the affected pa-
tients may have other manifestations, such as diarrhea or
abdominal pain. In contrast to other immunocompetent pa-
tients, fever or constitutional symptoms were occasionally
noted in the CKD patients with CMV GI disease.4 The most
common endoscopic finding of CMV GI disease was multiple
ulcers. However, the variable patterns of CMVGI diseasemay
be mistaken for candidiasis, polyps, or even malignancy.
Therefore, the final diagnosis relied on the histological find-
ings, including the presence of CMV inclusion bodies and the
immunohistochemistry or hybridization results. Other diag-
nostic tests, such as CMVantigenemia or serumCMV IgM,may
not be useful. Quantifying human CMV DNA is a novel methodree patients from the study hospital; patients had histopatho-
ed several yellow patches (arrow) with surrounding ulcers over
) uneven surface tumors (arrows) with bleeding (Case 3) or (C)
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who require preemptive therapy.15,16 However, assigning the
relevant GI symptoms/signs to CMV infection remains a
challenge. Therefore, diagnostic endoscopy and thebiopsyof
suspicious intestinal lesions are warranted.
The most common organ that was affected by CMV
infection in our CKD patients was the digestive system. This
result was different from the preferred organs in immuno-
compromised populations, such as HIV patients or trans-
plant recipients, in whom CMV infection often causes a
broad spectrum of diseases, such as meningoencephalitis,
pneumonitis, hepatitis, and retinitis.2,3 This difference is
potentially related to a selection bias in our study because
the clinical manifestations in organ systems other than the
GI tract affected by CMV infection might be obscured or
nonspecific, and the infected tissues are not easily avail-
able for histopathological or virological studies.
In our study, the most common comorbidities were dia-
betes mellitus and hypertension, which were also major
comorbidities of CKD in the general population.5 CKD pa-
tients with CMV infection tended to be older (age >70
years) and male sex compared with the general population
of CKD patients.5,6 In a meta-analysis of the outcome of
CMV colitis in immunocompetent hosts, there was a higher
mortality rate among males over age 55 and in patients with
renal failure or diabetes mellitus,14 which agrees with our
study result that more than one-third of CKD cases with
concomitant CMV infection were fatal.
Because our CKD patients with CMV infection had a low
BMI and serum albumin levels, a cohort of 24 malnourished
hemodialysis patients17 with a low mean BMI (21.1 kg/m2)
and serum albumin levels (mean 36 g/L) was selected for
comparison. The common underlying illness was similar in
both groups (i.e., diabetes mellitus and hypertension).
However, the average age of the malnourished group was
younger than that of our CKD patients with CMV disease
(mean, 60.6 vs. 66.1 years, respectively), which was in
accordance with previous studies that showed that older
CKD patients may be more vulnerable to CMV disease.18,19
There were several limitations in our study. First, the
diagnosis of CMV infection in our study relied on the his-
tology from biopsies or surgical resections. There may be
some selection bias because enteroscopy is the most readily
available and safe biopsy tool. Second, severe cases may
prompt attending physicians to investigate the causes and
report the results. Therefore, the morbidity and mortality
may be overestimated. Third, this is a retrospective study
with a limited number of cases; therefore, it is difficult to
estimate the impact of CMV disease in the CKD patients.
However, our results should bring CMV to the attention of
clinicians, who should perform early diagnostic and thera-
peutic interventions.
In conclusion, CMV disease may occur in CKD patients
without the presence of overt immunodeficiency. The GI
tract is the most common site of involvement. Clinicians
should be aware of this possibility in CKD patients who have
GI symptoms.
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